Osteolytic lesions marker in multiple myeloma

By Djunic Irena  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 237-240

Humana Press, Inc

Access to resources Recommend Favorite

Osteoprotegerin (OPG) Produced by Bone Marrow Stromal Cells Protects Breast Cancer Cells from TRAIL‐Induced Apoptosis

By Neville‐Webbe H.L.  

Breast Cancer Research and Treatment, Vol. 86, Iss. 3, 2004-08 ,pp. : 271-282

Springer Publishing Company

Access to resources Recommend Favorite

Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model

By Menu Eline   Leenheer Evy   Raeve Hendrik   Coulton Les   Imanishi Takeshi   Miyashita Kazuyuki   Valckenborgh Els   Riet Ivan   Camp Ben   Horuk Richard   Croucher Peter   Vanderkerken Karin  

Clinical and Experimental Metastasis, Vol. 23, Iss. 5-6, 2006-11 ,pp. : 291-300

Springer Publishing Company

Access to resources Recommend Favorite

Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein

By          

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3557-3562

Spandidos Publications

Access to resources Recommend Favorite

Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma

By Machaczka Maciej  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 539-543

Humana Press, Inc

Access to resources Recommend Favorite